Al Hammadi’s Pharma Serve wins SAR 347 mln contract

30/04/2018 Argaam

 

Saudi Arabia’s National Unified Procurement Co. (NUPCO) on Sunday awarded Pharma Serve, a subsidiary of Al Hammadi Company for Development and Investment, a two-year contract worth SAR 347 million to provide vaccines to government health authorities.

 

Pharma Serve is a wholly-owned subsidiary of Medical Support Services Company, which in turn is a subsidiary of Al Hammadi.

 

The deal’s financial impact is expected to show on Al Hammadi’s Q3 resultsthe Saudi healthcare firm said in a statement on Tadawul.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.